ImmunologybioRxiv
An adaptive control scheme for Interleukin-2 therapy
S. Khailaie, G. Montaseri, M. Meyer-Hermann
This paper develops an adaptive control strategy for IL-2 therapy to stabilize Treg populations and limit Tconv responses using a mechanistic model.
DOI 10.1016/j.isci.2020.101663